Kytopen

About:

Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.

Website: https://kytopen.com/

Top Investors: National Science Foundation, The Engine, MassVentures, Northpond Ventures, Alexandria Venture Investments

Description:

Kytopen is a developer of a cell therapy platform designed for non-viral delivery of molecules into hard-to-transfect immune cells. The company's technology combines microfluidics and automation to make non-viral delivery of molecules easier, faster and cheaper through an automated cell engineering platform, enabling researchers to find new discoveries in biology that will lead to cost effective cell and gene therapies.